Live Q&A: London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, invites shareholders to join the CEO, Suzy Dilly and Shareholder Representative, Adam Hargreaves in a Zoom webinar on 29 September 2022 at 1 pm (UK).
Registration prior to the event is recommended to ensure all notifications about the webinar are received by participants. Please register in advance of the event at: https://us02web.zoom.us/webinar/register/WN_LnCNxEbBSMOjzzYMxddhLA.
These r egistration details will also be available on the ValiRx website (https://www.valirx.com/contact). The format will comprise a “fireside chat” between Dr Dilly and Professor Hargreaves by the Company with shareholders invited to submit their questions prior to the event, or to activate their webcam and speak directly to ask their additional questions during the session. A recording of the event will be available to view from the ValiRx website shortly after the event concludes.
Industry Events: ValiRx participants are registered to take part in the Bio-Europe partnering conference in October (in-person) and November 2022 (virtual), seeking new project opportunities and introducing our expanded team and pipeline to other industry participants. Dr Dilly is also attending the BioTech Outsourcing Strategies conference in Manchester in November, where she is chairing a session of presentations.
The Directors of the Company take responsibility for this announcement.
*** ENDS ***
For more information, please contact:
ValiRx plc
Dr Suzanne Dilly, CEO
Dr Adam Hargreaves, Shareholder Representative
Tel: +44 (0) 2476 796496
